June 2, 2024

The Hong Kong Prize is one of Asia’s most prestigious prizes, recognizing scientific research with significant societal benefit. It provides funding to researchers, encourages young people to pursue their passions, and promotes high ethical standards worldwide.

The HK Prize is a prestigious competition that attracts authors from across the world and offers both cash awards and F&B vouchers to winners and runners-up. It also offers valuable writing experience and helps writers build their portfolio, especially for new authors.

This award is designed to encourage Hong Kong students of all ages to explore their unique perspectives on this year’s theme of ‘Our Changing World’, and to discover how the changes in our society, culture, technology, environment and politics affect each of us differently. Entries are open to all enrolled secondary school students in Hong Kong and must be nominated by their teachers.

As the censorship regime in China continues to deteriorate, it has become more important than ever to recognise and celebrate Hong Kong’s role as an international hub for free speech and human rights. In the face of the recent developments in mainland China, this year’s hk prize will honour two individual activists who are fighting for freedom.

Founded in 2007, Justice Centre Hong Kong ensures no one walks alone on their journey to protection, justice and a dignified life. Its work includes advancing the protection and inclusion of refugees, asylum seekers and other vulnerable migrants through legal and psychosocial assistance, advocacy and community initiatives.

In a letter to hk prize chairman Perry Link, 15 professors of Chinese studies and renowned dissident Cai Xia said: “These five Hong Kongers are worthy of this prize because they have risked their lives and careers to stand up for the values of democracy and freedom, and hold up a mirror to the ugly face of authoritarianism.”

The HK Prize honours excellence in early-career scholarship among scholars in the humanities, offering recognition and encouragement to young researchers. It has been revamped to include the First Book Prize in 2020, honouring monographs of scholarly value published or under contract for publication by a recognised academic press.

This prize is aimed at recognising the exceptional research conducted by young Fellows of the Academy on clinical practice and related areas of medicine. It is a highly prestigious award, and the winner will receive an engraved gold medal and a monetary award.

Using genome editing, Thein Swee Lay and Stuart Orkin have created a treatment for sickle cell disease by altering the BCL11A protein to reactivate fetal haemoglobin production. Their work is a paradigm of how basic discovery can translate to disease-fighting therapy. The Food and Drug Administration in the United States has approved two sickle cell therapies based on their work. They are among the first few to receive this prestigious prize.